Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors.
J Oncol Pharm Pract
; 26(8): 2068-2069, 2020 12.
Article
in English
| MEDLINE | ID: covidwho-883520
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
/
COVID-19
Type of study:
Observational study
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
J Oncol Pharm Pract
Journal subject:
Pharmacy
Year:
2020
Document Type:
Article
Affiliation country:
1078155220967100
Similar
MEDLINE
...
LILACS
LIS